Antithrombotic Activity of the Novel Oral Anticoagulant, Tecarfarin [Sodium 3-[4-((1,1,1,3,3,3-hexafluoro-2-methylpropan-2-yloxy) carbonyl) benzyl]-2-oxo-2H-chromen-4-olate] in Animal Models
S. Scott Bowersox, Daniel Canafax, Pascal Druzgala, Peter Milner, Jeffrey I. WeitzVolume:
126
Year:
2010
Language:
english
DOI:
10.1016/j.thromres.2010.08.025
File:
PDF, 411 KB
english, 2010